Rand Wealth’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.95M Hold
18,088
0.22% 110
2018
Q2
$1.99M Hold
18,088
0.22% 108
2018
Q1
$1.81M Sell
18,088
-135
-0.7% -$13.8K 0.2% 112
2017
Q4
$1.79M Hold
18,223
0.2% 114
2017
Q3
$1.71M Hold
18,223
0.2% 114
2017
Q2
$2.03M Buy
18,223
+188
+1% +$19.9K 0.27% 99
2017
Q1
$1.77M Hold
18,035
0.21% 112
2016
Q4
$1.66M Hold
18,035
0.21% 113
2016
Q3
$1.53M Sell
18,035
-695
-4% -$58.4K 0.2% 115
2016
Q2
$1.52M Hold
18,730
0.21% 114
2016
Q1
$1.34M Hold
18,730
0.19% 125
2015
Q4
$1.33M Sell
18,730
-17
-0.1% -$1.14K 0.19% 124
2015
Q3
$1.15M Buy
18,747
+17
+0.1% +$1.19K 0.17% 127
2015
Q2
$1.36M Buy
18,730
+135
+0.7% +$9.97K 0.18% 118
2015
Q1
$1.43M Hold
18,595
0.19% 115
2014
Q4
$1.33M Hold
18,595
0.18% 119
2014
Q3
$1.13M Hold
18,595
0.16% 113
2014
Q2
$1.09M Hold
18,595
0.16% 113
2014
Q1
$1.08M Sell
18,595
-3,000
-14% -$161K 0.19% 107
2013
Q4
$1.16M Buy
21,595
+600
+3% +$35.6K 0.2% 104
2013
Q3
$1.3M Hold
20,995
0.26% 93
2013
Q2
$1.27M Buy
+20,995
New +$1.25M 0.28% 88

Other funds holding DGX

Rand Wealth's DGX Position: Q3 2018 in Review

Rand Wealth held its Quest Diagnostics (DGX) position steady in Q3 2018 at 18,088 shares worth $1.95M. The position accounts for 0.22% of the portfolio, ranked #110.

Rand Wealth first reported a position in DGX in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.03M in Q2 2017. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • Rand Wealth held 18,088 shares of Quest Diagnostics worth $1.95M as of Q3 2018.
  • Rand Wealth left its Quest Diagnostics share count unchanged in Q3 2018.
  • Quest Diagnostics made up 0.22% of Rand Wealth's portfolio in Q3 2018, its #110 holding.
  • Rand Wealth first reported a position in Quest Diagnostics in Q2 2013 and has held it in 22 quarters since.
  • Rand Wealth's Quest Diagnostics position peaked at $2.03M in Q2 2017.
  • 673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.